News & Updates

Treatment with tildrakizumab in patients with moderate-to-severe scalp psoriasis helps reduce scalp itch and improve quality of life when compared with placebo, with no new safety signals, as shown in a phase IIIb study.

In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.

Undernutrition has been singled out as a potential risk factor for tuberculosis (TB) in a recent Cochrane review.

Patients with diabetes show high levels of acceptance and ability to adopt self-testing of glycated haemoglobin (HbA1c) despite facing issues in the insertion of test cartridges into the analyser, reports a study. Patients also express willingness to do self-testing in the future if such a service is available.

Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.